The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients (A6301086)

Clinical trial NCT00765063 · COMPLETED

Trial details

NCT number: NCT00765063
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diabetic Foot Ulcer

Start date: 2008-10-01
Primary completion: 2010-10-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.